Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 6 for:    Leber congenital amaurosis phase 3
Previous Study | Return to List | Next Study

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

This study is ongoing, but not recruiting participants.
Children's Hospital of Philadelphia
University of Iowa
Information provided by (Responsible Party):
Spark Therapeutics, LLC Identifier:
First received: October 21, 2009
Last updated: October 31, 2014
Last verified: October 2014